Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1 - Wikidata - wikimedia - TriplyDB

Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1

Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1

http://www.wikidata.org/entity/Q34292530

about

Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.The role of variants regulating metformin transport and action in women with polycystic ovary syndrome.A common 5'-UTR variant in MATE2-K is associated with poor response to metformin.An update on the pharmacogenomics of metformin: progress, problems and potential.The pharmacogenomics of membrane transporters project: research at the interface of genomics and transporter pharmacology.Genetic variants in transcription factors are associated with the pharmacokinetics and pharmacodynamics of metformin.Functional characterization of liver enhancers that regulate drug-associated transporters.Pharmacogenomics of membrane transporters: past, present and future Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3.The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin.The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin.Disposition of metformin: variability due to polymorphisms of organic cation transporters.Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics Mammalian MATE (SLC47A) transport proteins: impact on efflux of endogenous substrates and xenobiotics.Multidrug and toxin extrusion proteins as transporters of antimicrobial drugs.Emerging transporters of clinical importance: an update from the International Transporter Consortium.Pharmacogenetics: Implications for Modern Type 2 Diabetes Therapy.Structure and function of multidrug and toxin extrusion proteins (MATEs) and their relevance to drug therapy and personalized medicine.The hydrodynamic tail vein assay as a tool for the study of liver promoters and enhancers.Identification and Functional Characterization of ST3GAL5 and ST8SIA1 Variants in Patients with Thyroid-Associated Ophthalmopathy.Population pharmacokinetic study of memantine: effects of clinical and genetic factors.Differential increments of basal glucagon-like-1 peptide concentration among SLC47A1 rs2289669 genotypes were associated with inter-individual variability in glycaemic response to metformin in Chinese people with newly diagnosed Type 2 diabetes.INFLUENCE OF PHARMACOGENETIC POLYMORPHISMS AND DEMOGRAPHIC VARIABLES ON METFORMIN PHARMACOKINETICS IN AN ADMIXED BRAZILIAN COHORT.Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events.Rare Variants in the ABCG2 Promoter Modulate In Vivo Activity.Association of decreased mRNA expression of multidrug and toxin extrusion protein 1 in peripheral blood cells with the development of flutamide-induced liver injury.

P2860

Q30248914-B297EF99-E595-4B94-8DD0-18C8266784C7 Q30275579-2BD571E1-BBCE-4704-9363-8F477638948C Q30407583-1829DBFB-A221-4260-B06F-631212A4BB1F Q34003050-90B31497-B6C5-4F23-8E7C-E5FEDA2010BE Q34071782-508120D2-0DAF-40E8-A7B3-1991DEB13FD1 Q34224429-FF1228AE-67DB-468A-9C3B-0BC034B29EFB Q35583006-FD5DCE24-D0F3-4BC0-B42D-08C946A8371A Q35603055-3E2ABC80-64E2-4928-9E6A-FCD9F376D0A1 Q36095058-9CCB18BB-4271-4B14-B101-5C6B36A56A8A Q36899802-61D85CC2-A458-4BDC-8508-BC23B7A40438 Q36924379-390CAE2D-3DE5-4202-A9D1-D11BA7DF8C3D Q37848844-2AE3E06A-71D4-4A53-ADF4-9ED530B8D257 Q37860362-0A006368-698D-4BE1-80A1-29F5E9E40ECC Q37933394-89077BD7-AEBF-4D0D-88D7-DC08027D2FFF Q38042679-8961D293-8D64-441C-BBAB-20512C900964 Q38099192-71727121-146D-4EBF-BF4B-1AB2B87A76EB Q38816602-FADD17C7-B884-4E1D-B635-33381F2AE1B6 Q38831370-67555457-7C78-4512-A8B8-1F0830840238 Q42115595-B6B028CC-4F31-43CA-BC16-4061E93E34B7 Q42646967-1F152C5A-9C76-4FDA-88A8-A054DF33AC9B Q43752615-2F1ACD84-F018-4FB9-B3D9-B34A036CAC82 Q48099965-537F8F7E-CBCB-4AF4-91C4-950818A717CA Q48202910-93AB7BBC-140E-4834-BDFE-3386D35EE6A0 Q50511478-40CE1091-C77D-42D8-A82D-98081351A7AF Q51749326-97CDFBE4-F8C7-4E85-AF8D-606D9679E7E8 Q53547205-CEF29158-79D4-4530-8D2A-0AE445393DF8

P2860

Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1

http://www.wikidata.org/entity/Q34292530

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Identification and characteriz ...... f the human transporter, MATE1

@ast

Identification and characteriz ...... f the human transporter, MATE1

@en

Identification and characteriz ...... f the human transporter, MATE1

@nl

type

label

Identification and characteriz ...... f the human transporter, MATE1

@ast

Identification and characteriz ...... f the human transporter, MATE1

@en

Identification and characteriz ...... f the human transporter, MATE1

@nl

prefLabel

Identification and characteriz ...... f the human transporter, MATE1

@ast

Identification and characteriz ...... f the human transporter, MATE1

@en

Identification and characteriz ...... f the human transporter, MATE1

@nl

P1433

Q34292530-191603AE-28F0-45D8-8270-03B69EC23006

P1476

Q34292530-03171D3E-E6D7-4AA8-864B-CA69264CD49C

P2093

Q34292530-21E540C4-16C4-4FFE-A474-517380847851

Q34292530-2E6AE977-4E87-4F78-9E47-F3A1D2084C0E

Q34292530-364A31E9-B4A9-421C-BB4E-B94F8CC28005

Q34292530-3BCE38A9-E332-4C24-AF06-94322C106AAA

Q34292530-4EA436B0-6584-4FDA-8C26-13E5BA404D44

Q34292530-60663F0C-68B2-4E57-831A-5EA158AA93AF

Q34292530-902E87EC-4836-4676-9D27-0879D6807730

Q34292530-93049911-1C7E-4F52-A8EE-61B1878FA2BF

Q34292530-9C8BB3F8-1D63-4717-BA61-16138E09538A

Q34292530-AEEB28AC-7E34-4717-8776-6794AD274D31

P2860

Q34292530-09FDA923-B620-425D-8D80-6196149F71C0

Q34292530-0FE32C03-7A4E-465F-B801-D7C7A405E974

Q34292530-177DDA34-6E81-4576-BD2F-EFA32088F527

Q34292530-2C498766-595D-4E6A-ACE4-05610C8BCC50

Q34292530-3A84C963-D91A-4AB8-8E7F-81B82F18505A

Q34292530-433396FB-4AA8-48F8-A894-25A939D0BDB2

Q34292530-49099358-743C-4604-96EF-2E0A3B22C1A1

Q34292530-4A41C0D3-00D5-438E-9C63-CBB9B8CB5297

Q34292530-4BF3C591-BF66-434D-B592-08B2ADA2C11B

Q34292530-534E19CC-B810-4E7D-AADE-0C307E2DD63F

P304

Q34292530-9137A064-73A8-45C1-80AD-C31774D1F6C4

P31

Q34292530-219A6047-CB7A-4C1E-8430-491FAFC71768

P356

Q34292530-3247F462-0676-41EF-9712-AA3131B9AFCE

P433

Q34292530-28536990-420F-4D66-BCA8-CE48F5774C5B

P478

Q34292530-4DBAE839-3F6E-4BC8-B024-1D33CC3C8041

P50

Q34292530-00AF1FA9-9FC6-4457-81BD-FBEB7F1D487A

Q34292530-51D4B1D6-EC7D-4BAF-9624-3FCB6B846B19

Q34292530-F5EECC13-A82B-417D-99D7-BD758F8599AD

P577

Q34292530-1070AE64-C1BD-49D7-A82D-6B86B3628223

P698

Q34292530-CEA5B8F4-2288-4145-BA6A-817061AEAE77

P932

Q34292530-381D5C58-AF08-4E33-9F2E-6BB526CB26D1

P356

FPC.0B013E328330EECA

P1433

Pharmacogenetics and Genomics

P1476

Identification and characteriz ...... f the human transporter, MATE1

@en

P2093

Brain L Black

http://www.w3.org/2001/XMLSchema#string

Doug Stryke

http://www.w3.org/2001/XMLSchema#string

Jeong Ho Lee

http://www.w3.org/2001/XMLSchema#string

Ji Ha Choi

http://www.w3.org/2001/XMLSchema#string

Ji-One Kang

http://www.w3.org/2001/XMLSchema#string

Kathleen M Giacomini

http://www.w3.org/2001/XMLSchema#string

Loan Nguyen

http://www.w3.org/2001/XMLSchema#string

Mee J Kim

http://www.w3.org/2001/XMLSchema#string

Richard A Castro

http://www.w3.org/2001/XMLSchema#string

Sook Wah Yee

http://www.w3.org/2001/XMLSchema#string

P2860

Genomic structure and DNA binding properties of the human zinc finger transcriptional repressor AP-2rep (KLF12)

A human transporter protein that mediates the final excretion step for toxic organic cations

Transcriptional regulation of the AP-2alpha promoter by BTEB-1 and AP-2rep, a novel wt-1/egr-related zinc finger repressor

Sp1- and Krüppel-like transcription factors

Haploview: analysis and visualization of LD and haplotype maps

Critical roles of Sp1 in gene expression of human and rat H+/organic cation antiporter MATE1

Krüppel-like transcription factors: a functional family

Transport of paraquat by human organic cation transporters and multidrug and toxic compound extrusion family

Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters

Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters.

P304

770-780

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/FPC.0B013E328330EECA

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19745787

http://www.w3.org/2001/XMLSchema#string

P932

2976711

http://www.w3.org/2001/XMLSchema#string